Safety and efficacy study of intradetrusor injections of Botox [botulinum toxin A] for the treatment of urinary incontinence secondary to benign prostatic obstruction (BTX0621)

Trial Profile

Safety and efficacy study of intradetrusor injections of Botox [botulinum toxin A] for the treatment of urinary incontinence secondary to benign prostatic obstruction (BTX0621)

Recruiting
Phase of Trial: Phase II/III

Latest Information Update: 27 Feb 2017

At a glance

  • Drugs Botulinum toxin A (Primary)
  • Indications Benign prostatic hyperplasia; Overactive bladder
  • Focus Therapeutic Use
  • Most Recent Events

    • 28 Jul 2007 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top